#$%^&*AU2013204841B220160428.pdf#####A ROG:A001 ABSTRACT OF THE INVENTION The present invention includes a method of reducing or inhibiting the kinase activity of CKIT mutant trosine kinase activity in a cell or a subject, and the use of such compound for treating mutant C-KIT driven cell proliferative disorder(s) in a subject related to using a 5 compound of the present invention: 10 to A01 15A NN NH2 20 or pharmaceutically acceptable salt thereof. 22